"Inauguré en 1971, l’Hôpital privé de Parly 2 – Le Chesnay est un établissement de référence du département des Yvelines. Premier centre privé à avoir pratiqué la chirurgie cardiaque, il rejoint en 2006 le groupe Ramsay Santé. Au quotidien, plus d’une centaine de praticiens vous accueille dans un établissement moderne et doté d’un équipement de haut niveau."

During the past decade, CMC Parly II conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CMC Parly II" #1 sponsor was "LivaNova" with 3 trials, followed by "GCS Ramsay Santé pour l'Enseignement et la Recherche" with 2 trials sponsored, "Ramsay Générale de Santé" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Hospices Civils de Lyon" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CMC Parly II" #1 collaborator was "European Clinical Trial Experts Network" with 2 trials as a collaborator and "Private hospital Parly II" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CMC Parly II" are "Acute Myocardial Infarction" (1 trials), "Aorta Thoracic; Traumatic Rupture" (1 trials), "Aortic Aneurysm, Thoracic" (1 trials), "Aortic Diseases" (1 trials) and "Atrial Arrhythmia" (1 trials). Many other conditions were trialed in "CMC Parly II" in a lesser frequency.

Most popular intervention types in "CMC Parly II" are "Device" (7 trials), "Other" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "C1 Inhibitor Human" (1 trials), "DTA patients (Valiant)" (1 trials), "HSSA test" (1 trials), "Icatibant Injection" (1 trials) and "MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMC Parly II" are 11 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "CMC Parly II". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CMC Parly II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CMC Parly II, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".